LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 124 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 10.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,794,912 | -52.4% | 19,995,332 | 0.0% | 0.59% | -53.9% |
| Q2 2023 | $45,789,310 | +16.7% | 19,995,332 | +23.8% | 1.28% | -11.1% |
| Q1 2023 | $39,242,505 | +27.2% | 16,149,179 | 0.0% | 1.44% | +10.2% |
| Q4 2022 | $30,844,932 | -20.4% | 16,149,179 | 0.0% | 1.30% | -18.7% |
| Q3 2022 | $38,758,000 | +47.3% | 16,149,179 | +14.1% | 1.60% | +26.0% |
| Q2 2022 | $26,317,000 | -12.3% | 14,149,179 | -1.4% | 1.27% | +5.9% |
| Q1 2022 | $30,005,000 | -47.0% | 14,356,589 | -0.0% | 1.20% | -41.6% |
| Q4 2021 | $56,578,000 | -18.1% | 14,360,000 | 0.0% | 2.05% | -23.8% |
| Q3 2021 | $69,072,000 | +79.3% | 14,360,000 | +71.1% | 2.70% | +86.6% |
| Q2 2021 | $38,528,000 | -21.8% | 8,394,000 | 0.0% | 1.44% | -21.8% |
| Q1 2021 | $49,273,000 | +31.4% | 8,394,000 | -23.4% | 1.85% | +25.2% |
| Q4 2020 | $37,493,000 | – | 10,963,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |